A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects
Clinical trial NCT04372407 · COMPLETED
Trial details
- NCT number
- NCT04372407
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2020-09-29
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.